Concepedia

Marie Prewett

MP

Statistics

Publications

25

Citations

3.6K

H-Index

20

Active since

1992

Affiliations

Immune Modulatory Therapies (United States)(Current)

Eli Lilly (United States)

The Wistar Institute

Indianapolis Zoo

SciClone Pharmaceuticals (United States)

Marie Prewett is an author at Immune Modulatory Therapies (United States) specializing in oncology, pharmacology, and medicine.

Publications per year

1992–2015

25

Publications

25

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

Neil I. Goldstein, Marie Prewett, Kazys Zuklys et al. · PubMed · 1995 · 790 citations

, , +14

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Marie Prewett, JC Huber, Yiwen Li et al. · PubMed · 1999 · 660 citations

, , +16

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.

Marie Prewett, Andrea T. Hooper, Rajiv Bassi et al. · PubMed · 2002 · 354 citations

, , +13

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Douglas Burtrum, Zhenping Zhu, Dan Lu et al. · PubMed · 2003 · 349 citations

, , +15

The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma

Marie Prewett, Howard I. Scher, Patricia Rockwell et al. · Journal of Immunotherapy · 1996 · 244 citations · Full text

, , +16

1–5 of 25